Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.
Nucleophosmin 1 (NPM1) mutations are frequently found in patients with acute myeloid leukemia (AML) and the newly generated sequences were suggested to induce immune response contributing to the relatively favorable outcome of patients in this AML subset. We hypothesized that if an efficient immune...
Main Authors: | Kateřina Kuželová, Barbora Brodská, Ota Fuchs, Marie Dobrovolná, Petr Soukup, Petr Cetkovský |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0127637 |
Similar Items
-
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
by: Kateřina Kuželová, et al.
Published: (2018-01-01) -
Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.
by: Rupa Narayan, et al.
Published: (2019-01-01) -
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
by: Jabra Zarka, et al.
Published: (2020-06-01) -
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
by: Markéta Šašinková, et al.
Published: (2021-01-01) -
Nucleophosmin 1 expression in acute myeloid leukemia
by: Mohammad Davoudi, et al.
Published: (2015-09-01)